CanSinoBIO announced today that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) has granted Good Manufacturing Practices (GMP) certification for its COVID-19 vaccine, Convidecia™. Dr. Xuefeng YU, Chairman and Chief Executive Officer of CanSinoBIO, stated, “We are pleased to receive the GMP certificate by the European Union, which is a testament to our capability to safely and reliably produce COVID-19 vaccines when many countries around the world are still in desperate need of mass protection from this pandemic. We will continue to support the supply of COVID-19 vaccines to China and other markets and contribute to the global fight against the pandemic by protecting more people’s lives.” In order to receive GMP, a company’s quality control system and manufacturing facilities must be in compliance with the guidelines set by the European Union, as well as meet high production standards.
Read more here.
Don’t miss the next article from HealthFirst 100.
Join our mailing list to receive the latest posts from our blog directly in your inbox.